E-Prescribing Networks Merge to Push this Technology on the Market
By Raoul Railey
20:39, July 1st 2008
27 votes
Vote this story
E-Prescribing Networks Merge to Push this Technology on the Market

Surescripts, a company that was founded by two pharmaceutical associations, and RxHub LLC, owned by three major mail order pharmacies, CVS Caremark, Express Scripts and Medco Health Solution, have announced that they will merge in order to push the concept of electronic-prescribing further on the market.

The two networks consider that the main benefits that are to be drawn from prescribing medication online are the elimination of handwriting mistakes, the possibility that the doctor has at having an instant overview of his patients’ medication history, and the fact that insurance companies can easily monitor their clients’ health condition.

In spite of these benefits, most doctors have shown to be reluctant to the idea of sending prescriptions to pharmacies over the internet. Last year, only 10 percent of the doctors in the US have used these sorts of services, and only about 25 million prescriptions out of more than 1 billion have been sent over the internet. This happened because doctors want to be sure that the prescriptions reach their destination safely, and it seems that until now, no system has been able to guarantee this. However, the merger between Surescripts and RxHub, might be able to offer all the features that will make doctors feel safe.

The new network will be called Surescripts-RxHub and each of the founding companies will have an equal share. The company will be temporarily headed by two persons, the former CEO of Surescripts, Rick Ratliff, and his counterpart from RxHub LLC, J.P. Little.

It seems that the newly formed network will operate as a non profit organization, and that the fees they will ask pharmacies, doctor and insurance companies, will be just enough to keep it going.



© 2007 - 2008 - eFluxMedia
Share the News:
Del.icio.us Digg Stumble Upon Facebook Newsvine Mixx
dotclear

Other News in

FDA Issues Warning On Arthritis Drugs Over Deaths

FDA Issues Warning On Arthritis Drugs Over Deaths

The U.S. Food and Drug Administration issued a statement which highlights that manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and...

Extra Caution Over Immunosuppressive Drugs

Extra Caution Over Immunosuppressive Drugs

Drugs that work by suppressing the immune system to keep it from attacking the body, such as Humira, Cimzia, Enbrel, and Remicade were found to cause high risk of fungal infection. Therefore, the...

Rival Anchors Stand Up To Cancer

Rival Anchors Stand Up To Cancer

On Friday, three network news anchors teamed up in a massive campaign aimed to raise funds to develop breakthroughs that will put an end to cancer, CBS reported on its Web site. Hosts Katie Couric,...

Final Report On Bisphenol-A

A final report on bisphenol-A, a chemical usually used in polycarbonate plastics, has been released by the National Toxicology Program.Also known as BPA, the organic compound which is commonly used...

4 TNF-Blockers Get Stronger Warning Labels Due To Fatal Fungal Infection

4 TNF-Blockers Get Stronger Warning Labels Due To Fatal Fungal Infection

The Food and Drug Administration ordered stronger and additional warnings about the risk of presumptive fatal fungal infections, particularly one called histoplasmosis, in people taking four...

dotclear
Latest videos in Health
Mosquitoes Taking a Bite Out...
Olympic Swimmer Has Cancer...
Dorm Room Bedbugs
Dogs Can Smell Skin Cancer?
HealthWatch

dotclear
Health You are here: Health
» Science   » Health   
E-mail To A Friend Print RSS Text size: Decrease font size Increase font size
dotclear
dotclear
dotclear
Most Popular in Health
Researchers Detect Genetic Defects Guilty Of Deadliest Cancers

» read full story
dotclear

Interested In This Topic?

News Alert will keep you informed. Find out more.
dotclear
Photos Gallery
dotclear
Today's Latest News
On Your Marks! Get Set!  VMAs!On Your Marks! Get Set! VMAs!

» read full story
dotclear